Therefore, fecal occult blood test (FOBT) (11) and serum carcinoembryonic antigen (CEA) (12) detection are preferred as CRC biomarkers because of their accessibility and affordability. The gene discussed is CEACAM5; the disease is colorectal carcinoma.